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Chapter 1.                                                                                               
Site-Directed Mutagenesis of Conserved Amino Acids Residues in N5-
Carboxyaminoimidazole Ribonucleotide Mutase: converting N5-CAIR into 
Aminoinmidazole Ribonnucleotide carboxylase 
1.1. Introduction  
1.1.1. The role of purine nucleotides in cellular activity 
Purine nucleotides play an important cellular role. They are utilized in 
energy storage (ATP), the synthesis of cofactors (NADH, B-12) and in the 
synthesis of amino acids and secondary natural products. Given the 
importance of purines to the cell, it is not surprising that two pathways exist for 
their synthesis, namely the salvage and de novo biosynthetic pathways.1,2 
1.1.2. Salvage pathway 
 The salvage pathway is a “recycle” pathway, where free bases 
generated from the degradation of nucleic acids are used to prepare new 
nucleotides through multiple enzymes. There are two critical enzymes which 
are commonly used. Adenine phosphoribosyltransferase (APRT) catalyzes the 
attack of free adenine onto 5-phosphoribosyl-α-pyrophosphate (PRPP) to yield 
AMP and PPi (Scheme 1  Salvage pathway A). The other enzyme is 
hypoxanthine-guanine phosphoribosyltransferase (HGPRT) which catalyzes a 
similar reaction to transfer guanine to PRPP to generate GMP (Scheme 1  
Salvage pathway C). This enzyme also catalyzes the reaction of hypoxanthine 
with PRPP to give IMP (Scheme 1  Salvage pathway B).3  
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The amount of purine nucleotides prepared by the salvage pathway is 
about 1%, so the pathway is utilized predominately for cellular stasis. For cells 
undergoing division, new purine nucleotides must be created. They are 
synthesized from the de novo purine biosynthetic pathway.4  
1.1.3. De novo purine biosynthetic pathway 
 Unlike the salvage pathway, the de novo purine pathway synthesizes 
the purine heterocycle from basic building blocks（Figure 1）. In this pathway, 
PRPP is the starting substrate that is ultimately converted to IMP. The pathway 
is intriguing because of the interesting chemistry which occurs in the pathway 
and also because it is one of the few primary metabolic pathway which is 
different between microbes and humans.5 The difference is focused on the 
conversion of aminoimidazole ribonucleotides (AIR) to 4-carboxy-5-
aminoimidazole ribonucleotide (CAIR). In humans, AIR is directly converted to 
CAIR by the enzyme AIR carboxylase (Class II PurE), requiring CO2 as the one 
carbon substrate.  In most bacteria, two steps and two enzymes are needed to 
convert AIR to CAIR. Step one is catalyzed by N5-carboxyaminoimidazole 
ribonucleotide (N5-CAIR) synthetase (PurK) which converts AIR to N5-CAIR 
Scheme 1  Salvage pathway  
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with support of ATP and HCO3-. The second step is the conversion of N5-CAIR 
to CAIR catalyzed by N5-CAIR mutase (Class I PurE). 6,7 
 
Figure 1. The de novo purine biosynthetic pathway. The green square 
hights the difference between Class I and Class II PurEs found in 
microbes versus higher eukaryotes. The enzyme names and 
abbreviations of substrates can be found in Tables 1 and 2 
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Table 1. Enzymes in de novo purine biosynthetic pathway. 
Gene Enzyme name  
PurF PRPP amidotransferase 
PurD  GAR synthetase  
PurN  GAR transformylase 
PurT FGAR synthetase 
PurL FGAM synthetase 
PurM AIR synthetase 
Class II PurE  AIR carboxylase 
PurK N5-CAIR synthetase 
Class I PurE N5-CAIR mutase 
PurC SAICAR synthetase 
PurB Adenylosuccinate lyase 
PurH AICAR transformylase 
PurJ  IMP cyclohydrolase 
 
Table 2. Abbreviation of substrates  
Abbreviation of 
intermediate 
Full Name 
PRPP 5-Phosphoribosyl-α-pyrophosphate 
PRA 5-Phosphoribosylamine 
GAR Glycineamide ribonucleotide 
FGAR N-formylglycineamide ribonucleotide 
FARM N-formylglycineamidine ribonucleotide 
AIR Aminoimidazole ribonucleotide 
N5-CAIR N5-Carboxyaminoimidazole ribonucleotide 
CAIR 4-Carboxy-5-aminoimidazole ribonculotide 
SAICAR Succino 5-aminoimidazole-4-carboxaminde ribonucleotide 
AICAR Aminoimidazole-4-carboxamide ribonucleotide 
FAICAR 5-Formamido-4-imidazolecarboxamide ribonucleotide 
IMP Inosine monophosphate 
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1.1.4. PurK  
PurK is one of the ATP-grasp enzymes and its active site includes ATP, 
AIR and bicarbonate subsites.8 As mentioned above, PurK catalyzes the 
turnover of AIR to N5-CAIR. This is an ATP-dependent process and links CO2 
to the N5 amino group on AIR to generate N5-CAIR. However, PurK is not 
required under the condition of high CO2 concentration as AIR can be non-
enzymatically converted to N5-CAIR without the support of ATP.9 
1.1.5. N5-CAIR 
 N5-CAIR had not been known as an intermediate in the pathway until 
the 1990s. This is likely due to the fact that it is a highly unstable compound. It 
is sensitive to pH and temperature. At 30 ºC and pH 7.8, the half-life of N5-
CAIR is about 0.9 minutes, where it ready breaks down to AIR.10 The low 
stability has important implication for how bacteria handle this metabolic 
intermediate in the middle of a biosynthetic pathway. 
1.1.6. Class I and Class II PurEs 
 Previous studies have shown that the Class I and Class II PurEs are 
evolutionarily related to each other. Each catalyzes a reversible reaction to 
generate the same product, CAIR. In addition, both have extremely similar 
protein structures (Figure 2), and shared about 20-30% sequence identity with 
each other.11 Despite these similarities, there exist critical differences between 
these two classes of PurEs. 
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1.1.6.1. AIR is the substrate of Class II PurEs but not Class I PurEs 
When AIR is incubated with Class II PurEs in the presence of CO2, rapid 
CAIR formation is observed.12 In contrast, addition of N5-CAIR or PurK (to 
produce N5-CAIR in situ) fail to give a burst of CAIR formation.9 NMR studies 
on the conversion of CAIR by the Class II PurEs fail to detect any N5-CAIR and 
instead yield AIR.13  
1.1.6.2. N5-CAIR is the substrate of Class I PurE but not Class II PurE  
NMR spectroscopy was applied to investigate and analyze the reverse 
reaction of CAIR with Class I PurE. NMR analysis showed that CAIR is first 
converted into N5-CAIR which is then non-enzymatically converted to AIR.10 
This is a strong evidence that Class I PurE catalyzes N5-CAIR rather than AIR 
to form CAIR. Addition of CO2 to AIR and Class I PurE gives a decrease in 
absorbance (due to N5-CAIR formation) followed by an increase in absorbance 
due to CAIR formation. This study indicates that N5-CAIR, not AIR and CO2, 
are substrates for Class I PurEs. 13 
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P 
S 
Figure 2 Crystal structure of Class I and Class II PurEs structures. (A)Human 
PAICS (PBD 2H31) contains Class II PurE active sites and SAICAR synthetase 
active sites; (B) E.coli PurE (PBD 2ATE).(C) Superposed monomer structures of 
Class I (yellow) Class II (blue)PurE  
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1.1.7. Sequence and structural studies 
Figure 3. Sequence alignments between Class I and Class II PurEs. (A)  
Alignments between E.coli PurE and G.gallus PurE. Red cubes indicate 
universal conserved residues, and blue cubes indicates class specific 
residues. Sequence numbered after E.coli PurE. (B) Sequence alignments in 
40S and 70S loop numbered after Td PurE. Orange represent the universal 
conserved residues, green is Class I specific conserved residues, and blue is 
Class II specific conserved residues. Td is Treponema denticola; Af is 
Archaeoglobus, fulgidus; Aa is Acetobacter aceti; Ec is Escherichia coli  
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Previous studies of Class I and Class II PurEs have shown how similar 
these two enzymes are to one another. The crystal structures (Figure2) show 
that they are both symmetrical octamers formed by similar 17KD subunits.14,15 
In humans, Class II PurEs are fused with SAICAR synthetase (PurC), while 
bacterial Class I PurEs are usually expressed alone. For yeast and fungi, Class 
I PurEs are usually fused with PurK. The sequence alignment of Class I and II 
from different species indicates that both have several conserved regions 
(Figure 3A). P-loop, which is between the β1 and α1, is responsible for 
phosphate group. 40s loop is  located between β2 and α2, and 70s loop is 
located between β3 and α3.14,16  Sequences alignments of Class I and II PurEs 
in the 40s and 70s loops indicates that S38, A39, H40, A66, G67, and L72 are 
highly conserved amino acid residues for all PurEs (Figure3 B). However, 
there are residues which are only conserved in each class. In the 40s and 70s 
loop, Class I PurEs’ residues are conserved in R41, G68, A69, A70, H71,P73, 
while most Class II PurEs have K41, G68, S69, N70, G71,S73 at the same 
residues.11,15 One of the special case of Class II PurEs is Treponema denticola 
(Td) PurE, which is the only known bacterial AIR carboxylase.16  
The question of how these two similar enzymes catalyze different 
reactions is still unknown. The hypothesis is that the class specific conserved 
residues might be the key to determining the functional differences between 
these two classes of enzymes. However, few studies have been done on these 
residues and we don’t know which residues are important for the specificity of 
10 
 
 
 
the reaction. To investigate this issue, we conducted site-direct mutagenesis to 
convert conserved amino residues (41, 68, 69, 70, 71, and 73) of wild type 
Escherichia coli into residues which mimic those found in Class II PurEs. 
Mutants were then investigated to determine, which, if any, mutation produced 
a change in the specificity of the enzyme reaction. 
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1.2. Results 
The previous study of crystal structures of PurE shows that the active 
sites of PurEs are located in the P, 40s and 70s loops. Since the conserved 
residues on the P-loop are universally conserved, we did not alter these 
residues.15 We focused on the class-specific conserved residues found in the 
40s and 70s loops to investigate whether these residues affected the functional 
divergence between the two classes of PurEs.16  
Arg41, Gly68, Ala69, Ala70, His71 and Pro73, (numbered by Td PurE, 
(Fiugre 3B), are Class I PurE conserved residues and we mutated each of 
these residues to that found in the human region.a This gave mutants R41K, 
G68R, A70N, H71G and P73S. Since T.denticola PurE is a bacterial Class II 
PurE we also mutated His 71 to alanine.  
We investigated each of these mutants using developed assays, and 
compared them to the same kinetic studies of WT E.coli PurE. These studies 
were done to determine which amino acid(s) will decide the functional 
divergence between the two classes of PurEs. 
1.2.1. Enzyme expression and purification 
The cloning of PurE and plasmid purification was done by Aiko Hirata. 
The single mutants made are R41K, G68R, A70N, H71A, H71G and P73S. All 
plasmids were transformed into BL21/(DE3) competent cell for protein 
expression. All proteins were expressed and purified according to previously 
                                                           
a
 All the mutants cloning was done by Aiko Hirata from Dr. Fusao Hirata’s group  
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developed procedures.17 SDS-PAGE was utilized to check the protein 
purification of mutants. We obtained purified mutants R41K, G68R, A70N, 
H71A, and H71G. The P73S PurE, however, couldn’t be expressed and was 
therefore not purified.  
1.2.2. Protein folding of mutants  
1.2.2.1. Limited proteolysis for WT and mutant PurEs  
In order to check whether the mutants are folding properly, limited 
proteolysis assays were performed. It is expected that a correctly folded 
enzyme will be relatively stable to the serine protease, subtilisin, whereas an 
unfolded protein would be degraded completely.18,19 As showed in Figure 4, 
incubation of WT PurE with subtilisin for 1 hour leads to only a modest 
digestion as indicated by bands below the WT protein. This indicates that the 
protease only partly digests wild-type PurE. Analysis of mutants R41K, G68R, 
H71G and H71A with protease showed a pattern qualitatively similarity to the 
WT PurEs. However, A70N gave complete digestion indicating that this protein 
is partially unfolded or adopts an alternative conformation. 
13 
 
 
 
 
Figure 4 SDS-PAGE (15%) of 18 µg of wild-type or mutant (17kD) PurEs 
incubated with 18 µg subtilisin (27kD) for 1 hour. The reaction were stopped 
by addition of PMSF. Gel were photographed and the contrast was adjusted to 
provide the image seen here  
1 WT PurE 7 A70N 
2 WT PurE + Subtilisin 8 A70N+ Subtilisin 
3 R41K 9 H71A 
4 R41K + Subtilisin 10 H71A + Subtilisin 
5 G68R 11 H71G 
6 G68R + Subtilisin 12 H71G+ Subtilisin 
 
 
35kD 
25kD 
15kD 
10kD 
Lander 1 2 3 4 5 6 7 8 
 
Lander 9 10 11 12 
35kD 
25kD 
15kD 
10kD 
Subtilisin 
Subtilisin 
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1.2.2.2. Circular dichroism spectrum for folding of mutants 
 
 Circular Dichrosim (CD) can provide information on the structure of a 
protein. Usually, two UV regions are tested, the far-UV and near-UV. The 
absorption in the far-UV region (180nm-240nm) are mainly due to protein 
secondary structure (α-helix, β-sheet, etc.), while the near-UV (250nm-
290nm), where aromatic side chains can be detected, usually help to 
determine the tertiary protein structures.20,21 
The far-UV CD spectra showed that no significant change of H71G 
secondary structure compared to WT PurE (Figure 5). Near-UV CD spectrum 
gave, no significant data for either WT PurE or H71G PurE. This result 
indicates that the H71G mutant is folded properly. 
 
Figure 5 Far-UV CD spectra of H71G and Wild Type PurE in 100 mM 
Na3PO4 (pH, 7.4). The blue line represents 1.24 mg/mL of wild type PurE, 
while the red line is 1.15 mg/mL H71G. 
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1.2.3. Steady-State kinetic analysis of the PurE mutants  
The steady-state kinetic analysis for both WT and mutant PurEs was 
conducted using the CAIR decarboxylation assay.12 Kinetic constant were 
determined by curve fitting a plot of velocity versus CAIR concentration to the 
Michaelis Menten equation.22  
Table 3 Steady-State Kinetic Constants for Wild-type PurE and Mutants. Vmax and 
Km was determined by the CAIR decarboxylation assay system; kcat was 
calculated using the molecular weight of the octamer. 
PurE Mutants 
Vmax 
(μmol·min
-1
·mg
-1
) 
Km
（μM） 
kcat 
（min-1） 
relative kcat/Km 
(units/mg) 
kcat/Km 
min
-1
·M
-1
) 
Wild type 54 38 7297 1 1.9X10
8
 
G68R 19 32 2538 0.35 7.9X10
7
 
A70N 0.6 473 75 0.01 1.6X10
5
 
H71G 6 16 800 0.11 5.0X10
7
 
H71A 8 15 1111 0.15 7.4X10
7
 
R41K 1.5 37 204 0.03 5.5X10
6
 
 
As shown in Table 3, the catalytic proficiency of all mutants, as 
expected, are decreased about 3-100 fold. Since A70N is not folded properly, it 
is not surprising to see its low binding affinity and catalytic proficiency. The Km 
values are all within 2-fold of WT PurE suggesting that these mutants do not 
affect CAIR binding. The kcat/Km of WT and mutant PurEs are again similar. 
Overall, the kinetic studies indicate that these residues do not play a major role 
in either substrate binding or catalysis. Such a result may be expected give the 
fact that we made changes of conserved residues to amino acids that were 
conserved in the other class of PurE. A key question, though, is whether these 
mutants catalyze a different reaction from WT Class I PurE. 
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1.2.4. Comparison of the CO2 dependence of wild type PurE, human AIR 
carboxylases and mutant PurE   
Previous studies have shown that CO2 is the substrate only for AIR 
carboxylase. Class I PurEs are independent of the one-carbon substrate. 
However, N5-CAIR synthesis can occur non-enzymatically if enough CO2 is 
provided. Therefore, one way to distinguish Class I and Class II PurEs (AIR 
carboxylase) is by examining their dependence on CO2.14  
To determine this, reactions are examined at 10 ºC, where the rate of 
equilibrium between CO2 and HCO3- is decreased. Thus, at early time points, 
the predominant one-carbon species is the one added. When CO2 is added, 
AIR carboxylases rapidly converts AIR to CAIR.12 Addition of bicarbonate gives 
no conversion.  In contrast, when AIR is incubated with Class I PurE and CO2, 
no burst is observed.13 In fact, often a decrease in absorbance is seen.23 This 
decrease is due to the non-enzymatic turnover of AIR to N5-CAIR. At later 
times, CAIR production is seen as an increase in absorbance. 
As shown in Figure 6, addition of CO2 to WT PurE (blue line) generates 
a curve which shows a lag followed by an increase of CAIR production. 
Addition of CO2 to human AIR carboxylase (yellow line) gave a burst in CAIR 
formation. These results were used as controls for mutants. Incubation with 
bicarbonate, results in no or modest CAIR formation for either WT PurE, AIR 
carboxylase or the mutants (Figure 7).  
 
17 
 
 
 
 
Figure 6. 150 µm AIR incubated with wild type or mutants PurE in the 
presence of 20 mM CO2. Yellow line is the absorbance of 600 ng human 
AIR carboxylase incubated with CO2, blue line is the 180ng E.coli PurE 
incubate with CO2. Red line shows each mutants with CO2 20 mM with 
same specific activity (0.01µm·min-1). For comparison, the data for WT 
PurE and AIR carboxylase is shown with each mutant. (A) G68R 800 ng; 
(B) A70N 27 µg; (C) H71G 1.3 µg (D) H71A 1.2 µg (E) R41K 5.8 µg  
18 
 
 
 
   
Figure 7.  Comparaison of WT and mutant PurEs with CO2 or HCO3-. Orange 
lines represent enzymes incubated with 20mM CO2, green lines are enzymes 
with 20 mM HCO3-. (A) Wild-type PurE 180ng (B) Human AIR carboxylase 600 
ng ; (C) R41K 5.8 µg; (D) G68R 800 ng; (E) A70N 27 µg; (F) H71G 1.3 µg ;(G) 
H71A 1.2 µg. 
19 
 
 
 
G68R, R41K and A70N all show obvious delays(Figure 6)when 
incubated with CO2. This indicates that CO2 is not a substrate for these three 
mutants.  
H71G shows a burst upon the addition of CO2 and a slow increase when 
HCO3- added. This is very similar to the curve generated with AIR carboxylase 
(Figure 7 B&F) with CO2. In addition, it is interesting that the rate of CAIR 
production is greater than for human AIR carboxylase. In order to verify that 
CO2 was a substrate for H71G, carbonic anhydrase was introduced into the 
assay. Carbonic anhydrase rapidly establishes the equilibrium between CO2 
and bicarbonate.24  As showed in Figure 8, in the presence of carbonic 
anhydrase, the rate of CAIR production incubated with CO2 decreases due to 
rapid conversion of CO2 to bicarbonate. In contrast, incubation of H71G with 
bicarbonate and carbonic anhydrase leads to an increase in rate of CAIR 
production. This evidence shows that CO2, but not HCO3-, is the substrate for 
H71G. 
Figure 8 Mutation H71G with one-carbonate substrates incubated with 
1 µg carbonic anhydrase. 
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 H71A is another interesting mutant. Incubation with CO2 does not 
generate a burst, however CAIR production is much more rapid than for WT 
PurE. Incubation with HCO3- curve indicates that HCO3- is not the substrate for 
H71A. Thus, H71A appears to be a hybrid between Class I and Class II 
PurEs.The analysis of the use of CO2 as a substrate revealed that H71G and 
perhaps H71A could utilize CO2. This is a hallmark trait of AIR carboxylase and 
suggests that H71G may be an AIR carboxylase enzyme. However, these 
experiments do not indicate whether H71G has the ability to still utilize N5-
CAIR as a substrate. 
1.2.5. The PurC-coupled assay 
In order to determine whether AIR or N5-CAIR is the substrates for 
H71A and H71G, we used a PurK/PurC coupled assay (Figure 9). This assay 
was done to produce N5-CAIR in situ and to make CAIR production irreversible 
by converting it to SAICAR. SAICAR production is monitored at 282nm to 
indicate the production of CAIR.13 In the absence of PurK (Figure 10 A), almost 
no SAICAR is produced from AIR by WT E.coli PurE. In addition, this 
demonstrates that the non-enzymatic synthesis of N5-CAIR is not sufficient for 
turnover. This indicate that AIR, as expected, is not a substrate for WT PurE.  
In the contrast, addition of H71G or H71A gave an increase in SAICAR 
production, showing the AIR converted to CAIR in the absence of its 
conversion to N5-CAIR by PurK.  
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Figure 10 PurC coupled assay to monitor N5-CAIR turnover. Green lines are 
325 ng WT PurE; Yellow lines are 2 µg H71A; Red lines are 3 µg H71G. (A) 
Enzymes incubated without PurK; (B) enzymes incubated with 1.1 µg PurK. 
Figure 10 PurC coupled assay  
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Addition of excess PurK leads to the rapid conversion of AIR in to N5-
CAIR, and consequently, SAICAR is produced rapidly with WT PurE (Figure 10 
B, green line). This validates that N5-CAIR is the substrate of PurE. 
Interestingly, H71G also gave a bust of SAICAR production in the presence of 
PurK (Figure 10B, red line). The rate, however is lower than WT PurE. H71A 
shows a large burst of SAICAR production and appears it be faster than for WT 
PurE (Figure 10B, yellow line). 
These results indicate that AIR is a substrate for both H71A and H71G. 
However, each protein also appears to utilize N5-CAIR as a substrate. Thus, 
H71A and H71G are both AIR carboxylase and N5-CAIR mutase enzymes. 
This data suggests that His71 plays a critical role in the reaction specificity of 
these enzymes. 
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1.3. Discussion 
The purpose of the site-directed mutagenesis of N5-CAIR mutase is to 
find possible amino acid residues that might determine the functional 
divergence between Class I and Class II PurEs. Therefore, the residues 
chosen in this study are in the active sites of both Class I and II PurEs and, 
also, are specifically conserved in each type of PurE. We then mutated E.coli 
PurE conserved residues in the 40s and 70s loop to the corresponding 
conserved residues in human AIR carboxylase. We also mutated His71 to 
alanine because it is found in the only known bacterial AIR carboxylase, 
Treponema denticola PurE.16 For these studies, we were able to express and 
purify, mutants R41K, G68R, A70N, H71G and H71Ab.  
We examined the steady-state kinetics using CAIR which is a substrate 
for both classes of PurE. All mutants, except for A70N, are active with kcat 
values between 2 to 35 folded lower than WT E.coli PurE. Km values are 
roughly the same as WT PurE. A70N was excluded as it is folded incorrectly 
and its catalytic ability and binding affinity was very low. The kinetic studies 
indicated that the enzymes were active, but the assay could not provide 
information on what product, AIR or N5-CAIR, is produced from CAIR. Thus, 
the study could not determine whether the mutants are N5-CAIR mutases or 
AIR carboxylase. 
                                                           
b
 All numbered after the T. denticola PurE sequences 
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A key difference between N5-CAIR mutase versus AIR carboxylase is 
the fact that AIR carboxylase uses CO2 as a substrate and N5-CAIR mutase 
does not. Therefore, we evaluate whether CO2 was a substrate for the mutants. 
All mutants were studied at the same specific activity to ensure that any burst 
of CAIR production was due to CO2 and not elevated enzymes level. The 
experiments were also run at 10 ºC to slow the kinetics of the CO2/HCO3- 
equilibrium. The results indicates that H71G and maybe H71A utilized CO2 as 
a substrate. This suggests that these mutants are AIR carboxylase. 
The next question is whether N5-CAIR is still a substrate. To answer that 
question, we utilized the PurC coupled assay investigating the forward reaction.  
In this assay, PurC is added, in the presence or absence of PurK, to monitor 
CAIR synthesis via SAICAR production. In the absence of PurK, H71G and 
H71A produced SAICAR from AIR and residual CO2. This confirms the AIR 
carboxylase activity. However, addition of PurK results in a large burst of 
SAICAR production indicating that N5-CAIR is also a substrate. This assay 
shows that H71G and H71A can utilize both AIR and N5-CAIR as substrates. 
This demonstrates that the H71G and H71A mutants are both N5-CAIR mutase 
and AIR carboxylase enzymes. 
Based on these studies, His 71 seems to be very interesting residue and 
plays an important role in determine the functional divergence between human 
and bacteria PurEs.   
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1.3.1. Possible mechanism the conversion of N5-CAIR to CAIR.  
 
Currently, the most plausible mechanism for Class I PurEs is shown in 
Scheme 2. CAIR is first reversibly decarboxylated to the intermediate AIR·CO2 
complex which is then reversibly converted to N5-CAIR. Class II PurEs appears 
to only catalyze the first reversible conversion, CAIR to AIR·CO2.23,25 Structure 
studies on the active site of PurEs show that the aminoimidazole ring of CAIR 
is in the hydrophobic pocket of Class I PurE formed by conserved residues 
located in the 40s and 70s loops.15 The CO2 generated from CAIR 
decarboxylation is believed to bind at the bottom of the active site. Therefore, 
mechanistic and structural studies indicate that Class I PurEs can trap CO2 in 
the active site for the attacking AIR to produce N5-CAIR. Class II PursE allow 
CO2 to dissociate from AIR and, therefore, prevent the production of N5-
CAIR.14 However, Class II PurEs must also facilitate the binding of CO2 for 
CAIR formation. How this occurs is unknown.  
1.3.2. What role does His71 play in this mechanism? 
Structure studies on Acetobacter aceti PurE (Class I PurE) indicates that 
His59 and His89 (TdPurE His40 and His71) are in contact with the His59 and 
His89 from their neighboring subunits to form a twofold histidine chain. This 
chain is isolated from solvent and it has been speculated that the possible 
Scheme 2 Simple mechanistic model for Class I and Class II PurEs 
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function of this chain is to transfer protons from one site.26 Several studies 
have been done with these two histidine residues. His59 is a universally 
conserved residues in both Class I and Class II PurEs and is believed to be the 
general base needed for the reaction to form CAIR.14 Site-direct mutagenesis 
studies on this residue indicates that it is essential as mutation to other amino 
acids abolishes activity.27 On the other hand, our study on His71 agree with 
other’s studies which show that site-direct mutagenesis of  His71 decreases 
the enzyme  activity but the enzyme is still functional.26,27 However, 
examination on the reaction catalyzed by this mutant revealed that it has AIR 
carboxylase activity. Such a result has not been previously reported.  
 
Figure 11. Dimer structure of WT Class I PurE (2ATE). His 75 (same as TdPurE 
His 71) is shown in red. NAIR is an analogue of CAIR and shown to indicate the 
substrate binding site in the active site position. 
NAIR 
NAIR 
His71 
His71 
  
Scheme 3 Transfer 
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open channel between the two active 
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the H71G as the PurC assay in the absence of PurK, indicated turnover from 
AIR. How CO2 binds and what is the driving force for this binding is unclear.
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CAIR and AIR. The opening channel, as hypnotized above, may provide a CO2 
tunnel between two isolated active sites. Thus, CO2 dissociated from N5-CAIR 
in one active site may migrate through the channel to bind AIR in the 
connecting active site to produce CAIR. Such a mechanism model indicates 
that both N5-CAIR and AIR are substrates for AIR carboxylase. The CO2-
dependence on the reaction could be explained by the rapid production of N5-
CAIR which then deliveries the CO2 to the enzyme. N5-CAIR itself would not be 
turned over until enough AIR was produced to occupy the other active site.  
1.4. Future Studies  
According to the results and discussion above, we make a hypothesis 
that His 71 might be the critical conserved residue to determine the functional 
different and removal of histidine may open a channel between two actives for 
CO2 transferring. Therefore much more studies can be applied to prove that.  
Some Crystal structures studies should be done to prove whether the 
open channel exist and whether they can let CO2 go through. Also, there are 
some mutants have not been made properly, which might also important to 
determine or assist His 71 to determine the functional differences. 
Further studies on this mechanism will need to be done to validate this 
proposed mechanism.  
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Chapter 2.                                                                                           
Developing a High-Throughput Screening Assay for the Discovery of N5-
Carboxyaminoimidazole Ribonucleotide Mutase Inhibitors 
2.1. Introduction  
2.1.1. Drug Resistance and new antibiotics  
Since the 1970s, only two new classes of antibiotics (Linezolid, and 
Daptomycin) have been introduced to the market.30 However, infections due to 
resistant organisms have become much worse.31,32 Therefore, there is an 
urgent need for new targets of antibiotics. 
2.1.2. PurEs as a new target for antibiotic drug discovery 
The de novo purine biosynthetic pathway could be a potential target for 
the development of new antibiotics because the pathway is different between 
humans and bacteria.5 As mentioned in the first part of the thesis, Class II 
PurEs, found in humans, directly catalyze the conversion of AIR to CAIR, while 
Class I PurE, found in bacteria, turns N5-CAIR to CAIR.6 While Class I and 
Class II PurEs are similar, they each catalyze their own reaction and selective 
inhibition by NAIR suggests that small molecules can be found which can 
selectively inhibit one class over other.33 Therefore, PurEs could be a new 
antimicrobial drug target. 
2.1.3. High-throughput screening 
High-throughput screening (HTS) is utilized in drug discover, because it 
can screen thousands of compounds in a short period and can provide 
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potential “hits” for follow-up studies.34 Critical to the success of a HTS is a 
robust and rapid assay which is capable of detecting enzyme catalysis in a 
small volume with great sensitivity. A HTS assay must be rapid, sensitive and 
free from interference by other parts of the assay. A number of techniques 
have been used for HTS assay mostly fluorescence, absorbance, FACS and 
even imaging.35    
2.1.4. Limitation of CAIR decarboxylase assay 
Since no small molecule non-nucleotide inhibitors are known for N5-
CAIR mutase, the Firestine lab conducted a HTS based on the CAIR 
decarboxylase assay. While the assay worked, only one selective inhibitor was 
found and the assay suffered from false negatives. The possible reason for the 
unsuccessful HTS for N5-CAIR mutase inhibitors is the limitations of the CAIR 
decarboxylase assay.12 This assay is based on observing an absorbance 
change of CAIR at 260nm. Unfortunately, many organic small molecules also 
absorb in this region. To circumvent this problem, the absorbance of the 
compound was subtracted from each well. However, for highly absorbent 
compounds, this often lead to concerns over measuring the small change in 
CAIR absorbance due to catalysis. The potential inhibitors might be missed 
during the HTS. It is clear that a better HTS assay is needed for screening for 
inhibitors of N5-CAIR mutase. In this chapter, we will discuss the assessment 
of several potential assays for HTS of N5-CAIR mutase.36 
31 
 
 
 
2.2. Results and discussion 
2.2.1. AIR carboxylation assay  
Another classic assay for the study of PurE activity besides CAIR 
decarboxylation is the coupled N5-CAIR mutase assay which measures the 
conversion of N5-CAIR to CAIR by the production of SAICAR. This assay starts 
with AIR which is rapidly converted to N5-CAIR by PurK. Conversion of N5-
CAIR to CAIR is monitored by SAICAR synthetase at 282 nm or at 340 nm for 
ATP assumption.10,13 However, this assay not appropriate for HTS as several 
enzymes (PurK, PurC, PK, LDH and NADH) are involved and, therefore, it is 
hard to tell if the hits generated from HTS inhibit PurE the coupling enzymes. 
Thus, extensive deconvolution would be needed limiting its usefulness for HTS.  
 
Figure 12  Procedure of PurC coupled assay.  
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2.2.2. Thermoflour®  
 
 
The thermoflour® assay is based on measuring the changes in the 
protein melting temperature (Tm) upon the binding of a ligand (inhibitor).37 
Previous studies have shown that binding of small molecules can alter a 
protein’s melting temperature, by either stabilizing or destabilizing the folding of 
the protein.38 Therefore, compounds which bind to Class I PurEs could 
theoretically be screened by this method. 
For PurE, we followed the standard assay determined by Nisesn, et al.39 
SYPRO orange (ex=492 nm, em=610 nm) is a fluorescent protein dye whose 
fluorescence increases when a protein unfolds. We utilized a real-time (RT)-
PCR instrument to gradually increase the temperature from 25 to 95ºC, while 
monitoring the fluorescence. The Tm was determined from the melting curve 
by calculating the maximum of the first derivative.  
Figure 13  Fluorescence intensity versus temperature for unfolding PurEs 
in the presence of SYPRO orange (ex=492 nm, em=610 nm).  
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The melting curve of E. coli PurE is showed on Figure 13. PurE is 
stable until approximately 60 ºC at which point the fluorescence intensity 
increases rapidly due to the unfolding of PurE. The signal decrease from 75 ºC 
to 95 ºC is due to protein precipitation or aggregation. The calculated Tm of 
PurE is 68.12± 0.03 ℃, as determined by 8 replicate experiments. 
 
We next investigated the affect on the Tm as a function of inhibitor 
concentration. Figure 14  shows the Tm versus compound concentration. AIR 
was used as a positive control, because previous studies have shown that it 
binds to PurE.14 As expected, the fluorescence intensity increase as the 
concentration of AIR increased. Compound 1 {1-(4-ethoxyphenyl)-3-[(3-
Figure 14  The melting temperature versus the concentration of compounds. 
75 µg/ml PurEs incubated with different concentration (0.01 –1 mM) of 
compounds. Green line is AIR; Blue compound 1 (IC50=150 µM); Red line is 
DMSO.  
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pyridinylmethyl) amino]-2,5-pyrrolidinedione}studied as these were identified as 
binders in a  fragment screening study for PurE inhibitors.40 Preliminary 
experiments indicated that DMSO could affect the Tm, and the two compounds 
used in this experiment were dissolved in 100% DMSO. Therefore, we also 
measured the change in Tm at DMSO concentrations equivalent to what would 
be found for these two compounds. As shown in Figure 14, compound 1 and 
DMSO show an identical change. This indicates that both of the compounds 
have no significant affect on the PurE Tm change.   
Why did we fail to measure a change in Tm for compounds which have 
been shown to bind to PurE? One possible reason is that the binding between 
PurE and these two compounds is not tight enough. Another possibility is that 
the Tm of PurE is fairly high, thus changes in the stability of the protein are 
small and so difficult to measure. Alternately, at high temperature, binding of 
the compound to the enzyme is poor due to the deformation of the binding site. 
Ultimately, despite much effort, we were unable to find a condition that allowed 
us to detect binding of various compounds by alternation in Tm. Therefore we 
abandoned this assay. 
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2.2.3. Metal stopping assay 
2.2.3.1. Assay design and hypothesis 
Previous studies indicated that metal cations can chelate to CAIR so 
tightly that it stops PurE catalysis.41 The tight binding of metals (such as Ni+ 
and Zn2+) to CAIR suggested that this property may be useful to determine the 
concentration of CAIR, which in turn, could lead to a suitable assay for PurE. 
Two questions need to be answered before such an assay can be 
developed: which metal to use and how to detect the CAIR:metal concentration. 
Previous studies indicated that Ni+ and Zn2+ tightly bind to CAIR and, therefore 
stop the reaction. Zn2+ was chosen for our experiments as the previous studies 
showed that a CAIR:Ni+ complex had poor kinetic stability.41 To measure the 
concentration of CAIR-Zn2+, we utilized the Zn fluorescent dye, TSQ. When 
TSQ is incubated with Zn2+, a 1:2 complex is formed which is fluorescent 
(ex=360nm, em=490nm).42,43 In the presence of a high CAIR concentration, 
zinc would bind to CAIR instead of TSQ and the fluorescence would decrease. 
Such a competition assay between TSQ, CAIR and Zn2+ could provide a new 
assay for PurE. As CAIR decreases, due to PurE activity, more Zn2+ would be 
available to bind to TSQ and the fluorescent signal will increase. Using this 
method, we can calculate how much CAIR is converted by the enzyme, and, 
therefore, deduce the kinetic data for the enzyme. Ultimately, this assay may 
be applicable for HTS. 
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Figure 16.   Fluorescent signal scan (ex=360 nm) for Zinc, AIR and CAIR. 
Grey line is the buffer (50mM Tris-HCl, PH7), Purple line is 250 µM ZnSO4 in 
buffer; orange line is 250 µM CAIR in buffer; Red Line  is 250 µM ZnSO4 with 
250 µM CAIR in buffer; green line is 250 µM AIR; and blue line is 250 µM AIR 
with 250 µM ZnSO4.  
Figure 15.  Zn2+ stops PurE from converting CAIR to AIR.  Green line is 
60ng PurE incubated with 130 µM CAIR at room temperature; red Line is 
when 250 µM ZnSO4 added.  
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Figure 18.  CAIR concentration versus Fluorescence (ex=360 nm, em=485 
nm). CAIR from 0 to 250 µM incubated with 250 µM ZnSO4 in 96 wells plate. 
Each concentration of CAIR has 8 duplicates.  
Figure 17. Wavelength versus fluorescence (ex=360 nm). Green line is 100 
µM ZnSO4 incubated with 50 µM TSQ; Red line is when 50 µM CAIR was 
added into solution; Blue line is 550 µM CAIR was added.  
38 
 
 
 
 
2.2.3.2. Experiments and results 
Previous studies showed that 250 µm ZnSO4 totally stops E.coli PurE 
from converting CAIR to N5-CAIR.41 As shown in Figure 15, once Zn2+ is 
added, there is an immediate end to the PurE catalyzed conversion of CAIR to 
N5-CAIR.  Therefore, we utilized this condition. 
Incubation of TSQ with Zn2+ gave the expected fluorescent signal. 
However, addition of CAIR failed to decrease the signal. Therefore, we 
checked all compounds used in this assay and interestingly, found that Zn2+ 
plus CAIR generated a strong fluorescent signal at 460nm (Figure 16). This 
signal is close to Zn2+:TSQ complex fluorescent peak. Thus, we found that the 
Zn2+:CAIR complex interfered with the monitoring of Zn2+:TSQ complex 
formation. 
Figure 19  Fluorescent signal scan (ex=360nm) with PurEs. Green line 
represent that 250 µM CAIR incubated with 250 µM ZnSO4, Red line is when 
250 µM CAIR incubated with 3 µg E.coli PurE for 5 mins, 250 µM ZnSO4 was 
added to the mixture. 
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Based on these results, we redesigned the assay, using the Zn2+:CAIR 
fluorescent signal to calculate the CAIR concentration.  As shown in Figure 16 
and Figure 18, as the concentration of CAIR increases the fluorescence 
increases linearly. This provides an easy method to calculate CAIR 
concentration. In order for this PurE assay to work, AIR must not form a strong 
complex with Zn2+ nor must it generate a strong fluorescent signal. As showed 
in Figure 16, incubation AIR with Zn2+ yielded a fluorescent signal, but one 
with an intensity much lower than CAIR. In addition, the emission peaks are 
different between these two complexes; the peak of AIR complex is about 439 
nm while the CAIR complex peak shifts to 459 nm.   
Despite this preliminary results, experiments with PurE showed that the 
assay is not sensitive. As shown in Figure 19, the fluorescent signal change 
can only be observed when a large amount of PurE is added. The amount of 
PurE needed (3 µg) is about 60 times that used in the decarboxylation assay. 
This would require a large amount of enzyme for HTS. In addition, the small 
change in signal could make the assay difficult to use in a screening system 
where only a modest inhibition is frequently observed. Since the assay is not 
sensitive, we decided not to continue to work on this method. 
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Chapter 3                                                                                                    
Materials and Methods 
3.1 Materials  
All chemical compounds come from Fisher, Sigma-Aldrich, or Thermo 
Scientific. E.coli PurE mutants were prepared in pET-21 with a C-terminal his-
tag and contained additional sequences CTG GAG CAC CAC CAC CAC CAC 
CAC. These plasmids were cloned and amplified by Aiko Hirata. Sequences 
were verified by the DNA Sequencing Lab at Wayne State University. BL21 
(DE3) was obtained from New England Biolab Inc.. E.coli PurC was the kind 
gift of Dr. T. Joesph Kappock (Purdue University, West Lafayette). Wild-type E. 
coli PurK was expression and purified by Jordan Rantucci.    
All UV assays were conducted on a Cary 100 UV-vis spectrophotometer 
equipped with a temperature controller. Fluorescence was done using the 
Fluoro MAX®-3 with FluorEssence™ software. Circular Dichroism (CD） was 
conducted using Jasco J-1500 high performance CD spectrometer and access 
to this instrument was kindly provided by Dr. Timothy Stemmler. Thermal shift 
assays were conducted using the Mx3005P qPCR System and access to this 
instrument was kindly provided by Dr. Olivia Merkel.  
3.2 Expression and purification of WT and mutated PurEs 
E.coli BL21/(DE3) was transformed with plasmids containing mutants or 
wild-type PurEs cloned into pET-21. A single colony was incubated overnight at 
37 ºC in 5 ml LB medium with 50 mg/L ampicillin and the overnight culture was 
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diluted (1:100) into 500 mL LB medium with 50 mg/L ampicillin and incubated 
until an OD600 of 0.5 was obtained. Protein expression was induced by the 
addition of 0.1 M IPTG and incubated for an additional 4 hours. Cells were 
centrifuged (20,000 rpm) and stored at -20 ºC until use.  
For purification, bacterial cells were lyzed by addition of B-PER reagent 
(4 mL per gram of pellet, Pierce Biotechnologies) and incubated for 10 min. 
The resulting suspension was centrifuged at 20,000 rpm for 60 min (Beckman 
ultra-high-speed centrifuge, rotor JA-20) to remove cell debris. The clear 
supernatant was treated with streptomycin (5 mg/mL) and incubated for 2 
hours before precipitated nucleic acids were removed by centrifugation at 
20,000 rpm for 60 min. The supernatant was loaded, at 4 ºC, onto a column 
(10 mL) containing Cobalt RAPID RUN™ Agarose Beads (Gold Biotechnology) 
which had previously been pre-conditioned with buffer A (10mM sodium 
phosphate, 300 mM sodium chloride, and 10 mM imidazole, pH 7.4). The 
column was successively washed, at 4ºC, with Buffers A-D (Buffer A containing 
either 50 mM (B), 150mM (C), or 400 mM (D) imidazole). Fractions were 
collected and the PurE proteins eluted with buffer D. The purity of the protein 
was checked with 15% denatured SDS-PAGE. Purified PurE was dialyzed 
against 10 mM Tris-HCl, 200 mM NaCl, pH 8 and concentrated to at least 1 
mg/mL using an Amicon® centrifugal concentrator. The protein was stored in -
80 ºC. Protein concentrations were determined using the Coommassie 
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(Bradford) Protein Assay Kit following the manufactures instructions (Thermo 
Scientific).36  
3.3 Limited Proteolysis 
Limited proteolysis was conducted according to previous methods. (18) 
Briefly, wild type or mutant PurEs (18 µg) were added to 30 µL of buffer (50 
mM Tris-HCl, pH 8.0) and 0.18 µg of subtilisin (from Bacillus licheniformis) was 
added. The reaction was incubated on ice for 1 hour at which time it was 
quenched by the addition of 1 mM PMSF. Products of the proteolysis were 
examined using a 15% denatured SDS-PAGE stained with Commassie Blue.     
3.4 Circular Dichroism.  
Wild-type or mutant PurE was dissolved in buffer (NaPO4 100mM, pH 
7.4) to a final concentration of 1 mg/ml. The protein sample (70-100 µL) was 
loaded in a 0.2 mm path length cuvette and the CD spectrum was obtained at 
room temperature for far UV (190-250nm) and near UV (260-320nm).44    
3.5 Steady-state kinetic 
The assay contained 100 mM Tris-HCl (pH8), 6.25-150 µM CAIR and 
varied amounts of WT (48ng) or mutant PurEs (0.2-0.6 µg) in final volume of 
1mL in a 1cm path length cuvette. (12) The consumption of CAIR was 
monitored at 260nm at room temperature. A plot of initial velocity versus 
substrate concentration was generated and the data was fitted to the Michaelis 
Menten equation (1) and kinetic parameters were calculated by Kaleidagraph 
(Synergy).22 
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3.6 CO2-dependence assay 
 To a stopper-fitted cuvette containing 100 mM Tris-HCl, pH 8, 3U of WT 
or mutant PurEs was added along with 125 µM AIR. The reaction was 
incubated at 10 ºC for a min. In some experiment, 1µg/mL carbonic anhydrase 
was also added. Reaction was initiated by addition of 20 mM CO2 or NaHCO3. 
CO2 solutions were prepared by continuous bubbling CO2 into 100mL distilled 
de-ionized H2O at 4ºC and the concentration was estimated by the solubility 
constant of CO2 (0.2871g/100g of water).13  
3.7 PurC coupled assay. 
A cuvette with a 1mL final volume containing 100 mM HEPES, pH 7.5 
buffer, 20 mM KCl, 6 mM MgCl2, 2 mM PEP, 100 µM ATP, 10mM aspartic acid, 
4 U of pyruvate kinase, 17 U lactate dehayrogenase and 100 µM NADH was 
incubated at 37 ºC for 5 minutes. To this, E. coli PurC (13.5 µg) was added 
along with PurK (0 or 11.5 µg) and WT or mutant PurE (6U). The reaction was 
initiated by adding 60 µM AIR and SAICAR synthesis was monitored at 282 
nm.9,10,45 
3.8 Thermoflour®  
In a 0.2 mL PCR tube, 10 mM HEPES (pH7.5) buffer was added along 
with150 mM NaCL, 5X SYPRO Orange, and 75 µg/ml of E.coli PurE, (0-1mM) 
AIR or, 1-(4-ethoxyphenyl)-3-[(3-pyridinylmethyl)amino]-2,5-pyrrolidinedione 
(1) 
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(ChemBridge Corporation). The final volume was 30 µL, Thermal melting was 
done using a RT-PCR instrument from 25-95 ºC while monitoring fluorescence 
of SYPRO orange (ex=492 nm, em=610 nm). The melting temperature was 
calculated from the maximum of first derivate curve.39 For studies of ligand 
induced changed in the Tm, the same experiment was repeated in the 
presence of various concentrations of ligand. 
3.9 Metal stopping assay. 
In a final volume of 1mL containing 50 mM Tris-HCl (pH 7) buffer,  250 
µM CAIR or AIR was added along with E.coli PurE (0-3 µg) and the reaction 
was incubated at room temperature for 10 minutes. The reaction was 
quenched by the addition of 250 µM ZnSO4 and fluorescence was determined 
from 400-600 nm while being excited at 360nm. The same concentration and 
method was applied to a 96-well microplate using a 100 µL per well final 
volume. Fluorescence data was collected using the Multi-Mode Microplate 
Reader (Synergy) with the excitation filter set at 360 nm and the emission filter 
set at 485 nm.41 
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ABSTRACT 
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The de novo purine biosynthesis pathway plays a critical role in 
providing new purines to the cell. Previous studies have shown differences 
between the human and bacterial pathways which suggests that pathway may 
be a potential target for antibiotic drug discovery. Three critical enzymes are 
involved in the pathway divergence. In the bacterial pathway, N5-CAIR 
synthetase (PurK) first converts AIR to N5-CAIR, which is then transformed into 
CAIR catalyzed by the enzyme N5-CAIR mutase (Class I PurE). In the human 
pathway, AIR carboxylase (Class II PurE) catalyzes the direct conversion of 
AIR to CAIR. Class I and Class II PurEs have structure and sequence 
similarities but also are functionally different. However, the residues 
responsible for these differences are unknown. In this study, we hypnotized 
that the class-specific conserved residues in the active site might be the key to 
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determining the functional differences between the two PurEs. Site-directed 
mutagenesis was used to convert residues of Class I PurEs to Class II PurEs. 
Several mutant PurEs were made and examined for CO2-dependent 
conversion of AIR to CAIR. Two mutants H71A and H71G displayed CO2 
dependent that was similar to that observed for AIR carboxylase. Additional 
studies revealed that these enzymes also were capable of using N5-CAIR as a 
substrate. This indicates that the H71A and H71G mutant have AIR 
carboxylase as well as N5-CAIR mutase activity. Examination of the crystal 
structure of N5-CAIR mutase indicates that His71 is at the bottom of the active 
site and removal of this residue creates a channel between active sites in two 
subunits. We speculate that this channel may be key for the utilization of CO2. 
The second project focused on developing an appropriate high-
throughput screening (HTS) assay for Class I PurE inhibitor. Existing assays 
have significant issue for HTS. We examined both a thermo shift assay as well 
as a metal stopping/fluorescence assay. While both assays had some potential 
issues for analysis indicated that neither assay was suitable for HTS. 
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